MXELOXIRI versus FOLFOX/FOLFIRI Combined With Molecular Targeting Drug in the First-line Treatment of Patients With Initially Unresectable Metastatic Colorectal Cancer: A Phase II, Randomized, Prospective Controlled Trial

ABSTRACT: Interventions: Experimental group:mXELOXIRI;Control group:FOLFOX/FOLFIRI Combined With Molecular Targeting Drug Primary outcome(s): Objective response rate Study Design: Parallel

DISEASE(S): Initially Unresectable Metastatic Colorectal Cancer

PROVIDER: 2687497 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR